Finance

Fed rate hike splits analysts on prospects for year-end stock rally

Higher borrowing costs have raised concerns about equities, but Citadel Securities and Goldman Sachs point to historical evidence of a later recovery.

Editorial persona
Owen Mercer
Markets and Finance Editor
Published
Draft
Source: Yahoo Finance · View original source
Man in suit wearing an earpiece stands among traders and electronic market screens.
US markets

Analysts are divided over whether the Federal Reserve’s interest-rate hike will weigh on US equities or leave room for a year-end rally. The S&P 500 rose 1.14% on Thursday as Treasury yields and oil prices fell, according to Yahoo Finance’s report on analysis published by The Daily Upside.

Macro Risk Advisors chief executive Dean Curnutt warned clients that higher rates could trigger an S&P 500 pullback of up to 10%. He cited pressure on corporate margins, increased borrowing costs and the potential for slower consumer spending.

The concerns echo market conditions in 2018, when a September rate hike coincided with rising bond yields and a rotation away from highly valued technology stocks. Goldman Sachs chief executive David Solomon has also said the bank’s fixed-income trading business has been “a little bit softer”, while Goldman shares fell 4% on Wednesday.

Citadel Securities said it had become “increasingly constructive” about the market’s end-of-year prospects. The trading firm found that the S&P 500 had fallen an average 1.1% in the final two weeks of September since 1930 before rebounding in October.

Goldman Sachs said the index had declined by an average 2% during the first three months of seven rate-hiking cycles, but ultimately gained an average 9% over the following 12 months. The historical comparisons do not establish that the same pattern will repeat in current conditions.

Continue reading

More from Finance

Read next: Healthpeak lifts 2026 guidance after leasing gains and asset sales
Read next: Grayscale sees limited crypto impact from another 2026 Fed hike
Read next: Johnson & Johnson preferred over Kenvue for long-term dividend investors